A recent study published in JAMA Internal Medicine compared responses generated from AI-based chatbots to those of physicians in answering patient questions, and found that the chatbot responses were often superior in both quality and empathy. Out of 195 patient...
The Business of Pharmacy Podcast
Episode: The Inner Workings of Reverse Distribution | Michael Zaccaro, CEO, Pharma Logistics
Drug shortages, particularly for generic drugs, are a growing problem in the United States, with no clear path to resolving them, according to experts. The reasons for shortages vary, including unexpected demand spikes, manufacturing issues, tight ingredient...
RxPost protects your data in transit and at rest by utilizing various Amazon Web Services such as WAF, CloudFront, as well as Certificate Manager for always up-to-date SSL certificates. Our ACH Partner, Dwolla, implements a Know Your Customer program to ensure...
Your pharmacy’s bottom line needs a smarter pricing system to keep up with a tech-smart customer. But when should you make the move?
Pharmacies face new challenges every day. But those challenges bring a ton of opportunity. In fact, there’s never been a better time...
- People living with type 2 diabetes can now take Rybelsus® , the first and only oral glucagon-like peptide-1 (GLP-1) analog, along with diet and exercise, as initial therapy to help lower their A1C
- Since its approval, Rybelsus® has been prescribed to hundreds of...
The Food and Drug Administration is considering a major shift in the nation’s COVID-19 vaccine strategy.
The goal is to simplify vaccination against COVID and perhaps adopt an approach similar to what is used for the flu vaccine, with annual updates to match...
With the launch of ChatGPT, AI tech has become the latest hot topic. With the growth of digital health and virtual care, the pharmacy industry is ripe for innovation. But the pharmacy profession is often focused on “damage control,” and they miss out on the potential...
During President Joseph Biden’s State of the Union address on Tuesday night, he discussed key concerns in health care, with a focus on drug pricing, COVID-19, and accessibility. In his comments on drug pricing, Biden discussed the recent $35 cap on insulin prices for...